Role of Nox4 in murine models of kidney disease

Andrea Babelova1, Despina Avaniadi, Oliver Jung

  • 1Institut für Kardiovaskuläre Physiologie, Goethe-Universität Frankfurt am Main, Germany.

Insights

Nox4 (NADPH oxidase 4) does not drive kidney disease in vivo. Studies in mouse models suggest Nox4 may limit injury and disease progression under certain conditions, contrary to prior cell culture findings.

Area of Science:

  • Nephrology
  • Biochemistry
  • Molecular Biology

Background:

  • Nox4, a major hydrogen peroxide producer in the kidney, is implicated in epithelial cell injury and diabetic dysfunction in cell cultures.
  • Its specific role in in vivo renal pathology remains largely undetermined.

Purpose of the Study:

  • To investigate the in vivo role of Nox4 in three distinct models of experimental kidney injury.
  • To determine if Nox4 acts as a driver of renal pathology or offers protective effects.

Main Methods:

  • Utilized Nox4-inducible and constitutive knockout mouse models.
  • Examined streptozotocin-induced diabetes, unilateral ureteral ligation (UUO), and 5/6 nephrectomy (5/6Nx) models.
  • Quantified hydrogen peroxide production, albuminuria, matrix deposition, and inflammatory markers.

Main Results:

  • Nox4 deletion exacerbated albuminuria in diabetic mice but did not alter matrix deposition.
  • Unilateral ureteral ligation in Nox4 knockout mice showed increased ICAM1, CTGF, and fibronectin.
  • No significant differences in hypertension or albuminuria were observed in the 5/6Nx model between strains.
  • Renal Nox4 expression decreased during disease progression in diabetes and UUO models.

Conclusions:

  • In vivo data do not support Nox4 as a primary driver of kidney disease.
  • Nox4 may exert a protective role, potentially limiting injury and disease progression in specific renal injury contexts.

Related Concept Videos